Ardelyx reported $89.66M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Abbott USD 6.65B 787M Jun/2026
Amgen USD 5.87B 1.02B Mar/2026
Ardelyx USD 89.66M 24.7M Mar/2026
aTyr Pharma USD 987.07K 797.07K Mar/2026
Corcept Therapeutics USD 252.09M 90.07M Jun/2026
Curis USD 1.14M 8.86M Dec/2025
Sanofi EUR 8.11B 343M Mar/2026
TG Therapeutics USD 199.14M 27.73M Jun/2026
United Therapeutics USD 683.8M 35.7M Jun/2026